Atlas Trials

A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia

Clinical trial NCT06073769 · RECRUITING

Trial details

NCT number
NCT06073769
Sponsor
Bristol-Myers Squibb
Status
RECRUITING
Study type
OBSERVATIONAL
Acute Myeloid Leukemia
Start date
2023-11-15
Primary completion
2027-07-30
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.